Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Dahlmann

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|May 16, 2016
Repositioning of drugs for intervention in tumor progression and metastasis: Old drugs for new targetsGiridhar Mudduluru, Wolfgang Walther, Dennis Kobelt, et al.
Oncotarget|August 11, 2012
Systemic shRNA mediated knock down of S100A4 in colorectal cancer xenografted mice reduces metastasis formationMathias Dahlmann, Ulrike Sack, Pia Herrmann, et al.
Clinical & Experimental Metastasis|February 5, 2019
Pressurized intraperitoneal aerosol chemotherapy and its effect on gastric-cancer-derived peritoneal metastases: an overviewMiguel Alberto, Andreas Brandl, Pankaj Kumar Garg, et al.
British Journal of Cancer|May 21, 2022
Calcium-binding protein S100P is a new target gene of MACC1, drives colorectal cancer metastasis and serves as a prognostic biomarkerFelicitas Schmid, Mathias Dahlmann, Hanna Röhrich, et al.
Cancers|June 7, 2020
Small Ones to Fight a Big Problem-Intervention of Cancer Metastasis by Small MoleculesDennis Kobelt, Mathias Dahlmann, Malti Dumbani, et al.
Cancer Metastasis Reviews|January 5, 2019
MACC1-the first decade of a key metastasis molecule from gene discovery to clinical translationHarikrishnan Radhakrishnan, Wolfgang Walther, Fabian Zincke, et al.
Oncotarget|June 23, 2014
RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasisMathias Dahlmann, Anna Okhrimenko, Patrick Marcinkowski, et al.
Thyroid : Official Journal of the American Thyroid Association|March 7, 2015
RAGE Mediates the Pro-Migratory Response of Extracellular S100A4 in Human Thyroid Cancer CellsManoj Reddy Medapati, Mathias Dahlmann, Saeid Ghavami, et al.
Oncogene|August 25, 2022
Combinatorial treatment with statins and niclosamide prevents CRC dissemination by unhinging the MACC1-β-catenin-S100A4 axis of metastasisBenedikt Kortüm, Harikrishnan Radhakrishnan, Fabian Zincke, et al.
Oncotargets and Therapy|December 26, 2018
Expression of activating transcription factor 5 (ATF5) is increased in astrocytomas of different WHO grades and correlates with survival of glioblastoma patientsJonas Feldheim, Almuth F Kessler, Dominik Schmitt, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|May 16, 2016
Repositioning of drugs for intervention in tumor progression and metastasis: Old drugs for new targetsGiridhar Mudduluru, Wolfgang Walther, Dennis Kobelt, et al.
Oncotarget|August 11, 2012
Systemic shRNA mediated knock down of S100A4 in colorectal cancer xenografted mice reduces metastasis formationMathias Dahlmann, Ulrike Sack, Pia Herrmann, et al.
Clinical & Experimental Metastasis|February 5, 2019
Pressurized intraperitoneal aerosol chemotherapy and its effect on gastric-cancer-derived peritoneal metastases: an overviewMiguel Alberto, Andreas Brandl, Pankaj Kumar Garg, et al.
British Journal of Cancer|May 21, 2022
Calcium-binding protein S100P is a new target gene of MACC1, drives colorectal cancer metastasis and serves as a prognostic biomarkerFelicitas Schmid, Mathias Dahlmann, Hanna Röhrich, et al.
Cancers|June 7, 2020
Small Ones to Fight a Big Problem-Intervention of Cancer Metastasis by Small MoleculesDennis Kobelt, Mathias Dahlmann, Malti Dumbani, et al.
Cancer Metastasis Reviews|January 5, 2019
MACC1-the first decade of a key metastasis molecule from gene discovery to clinical translationHarikrishnan Radhakrishnan, Wolfgang Walther, Fabian Zincke, et al.
Oncotarget|June 23, 2014
RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasisMathias Dahlmann, Anna Okhrimenko, Patrick Marcinkowski, et al.
Thyroid : Official Journal of the American Thyroid Association|March 7, 2015
RAGE Mediates the Pro-Migratory Response of Extracellular S100A4 in Human Thyroid Cancer CellsManoj Reddy Medapati, Mathias Dahlmann, Saeid Ghavami, et al.
Oncogene|August 25, 2022
Combinatorial treatment with statins and niclosamide prevents CRC dissemination by unhinging the MACC1-β-catenin-S100A4 axis of metastasisBenedikt Kortüm, Harikrishnan Radhakrishnan, Fabian Zincke, et al.
Oncotargets and Therapy|December 26, 2018
Expression of activating transcription factor 5 (ATF5) is increased in astrocytomas of different WHO grades and correlates with survival of glioblastoma patientsJonas Feldheim, Almuth F Kessler, Dominik Schmitt, et al.
Pageof 3